• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母胎界面源自滋养层和蜕膜抑制细胞的免疫调节分子。

Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface.

作者信息

Clark D A, Slapsys R, Chaput A, Walker C, Brierley J, Daya S, Rosenthal K L

出版信息

Am J Reprod Immunol Microbiol. 1986 Mar;10(3):100-4.

PMID:2940880
Abstract

The mammalian fetus expresses a variety of paternal histocompatible, oncofetal, and trophoblast antigens against which the mother can mount an immune response. Survival of the "fetal graft" appears to depend upon local immunosuppressive mechanisms in lymph nodes draining the uterus and at the intrauterine implanation site itself. Nonspecific not-T-Fc-receptor-bearing small lymphocytes containing cytoplasmic granules present in successfully allopregnant mice can suppress both the generation of maternal-antipaternal killer T cells and the infiltration of cytotoxic T lymphocytes into sponge-matrix allografts during the effector phase of the immune response. These suppressor cells are deficient at the implantation sites of xenogeneic and allogeneic mouse embryos that are susceptible to maternal immunity and are destined to resorb. A soluble suppressor factor of approximately 100,000 daltons in size can be obtained from the suppressor cells and acts to block the response of T cells to interleukin-2 by interfering with IL-2 receptors. The development of the suppressor cells in the decidua requires certain hormonal signals as well as signals provided by trophoblast cells. Freshly explanted or cultured murine trophoblast cell lines elaborate soluble factor(s) that are active in recruitment or activation of suppressor cells. Since suppressor cells may be isolated from decidua of successfully allopregnant humans, the suppressor cell mechanism and its regulation may represent a key factor in the protection of the "fetal allograft" from rejection by maternal immunity.

摘要

哺乳动物胎儿会表达多种父系组织相容性、癌胚和滋养层抗原,母体可针对这些抗原产生免疫反应。“胎儿移植物”的存活似乎取决于子宫引流淋巴结及子宫内着床部位本身的局部免疫抑制机制。在成功进行同种异体妊娠的小鼠中存在的含有细胞质颗粒的非特异性非T-Fc受体-bearing小淋巴细胞,在免疫反应的效应阶段,既能抑制母体抗父系杀伤性T细胞的产生,也能抑制细胞毒性T淋巴细胞向海绵基质同种异体移植物中的浸润。在易受母体免疫影响并注定会吸收的异种和同种异体小鼠胚胎的着床部位,这些抑制细胞是缺乏 的。一种大小约为100,000道尔顿的可溶性抑制因子可从抑制细胞中获得,其作用是通过干扰IL-2受体来阻断T细胞对白介素-2的反应。蜕膜中抑制细胞的发育需要某些激素信号以及滋养层细胞提供的信号。新鲜分离或培养的小鼠滋养层细胞系会分泌可在募集或激活抑制细胞中起作用的可溶性因子。由于可从成功进行同种异体妊娠的人类蜕膜中分离出抑制细胞,抑制细胞机制及其调节可能是保护“胎儿同种异体移植物”免受母体免疫排斥的关键因素。

相似文献

1
Immunoregulatory molecules of trophoblast and decidual suppressor cell origin at the maternofetal interface.母胎界面源自滋养层和蜕膜抑制细胞的免疫调节分子。
Am J Reprod Immunol Microbiol. 1986 Mar;10(3):100-4.
2
Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.妊娠小鼠宿主抗移植物反应的主动抑制。VI. 从同种异体妊娠小鼠蜕膜获得的可溶性抑制活性可阻断对白细胞介素2的反应。
J Immunol. 1985 Mar;134(3):1659-64.
3
Active suppression of host-vs-graft reaction in pregnant mice. VII. Spontaneous abortion of allogeneic CBA/J x DBA/2 fetuses in the uterus of CBA/J mice correlates with deficient non-T suppressor cell activity.孕鼠体内宿主抗移植物反应的主动抑制。VII. CBA/J小鼠子宫内同种异体CBA/J×DBA/2胎儿的自然流产与非T抑制细胞活性不足相关。
J Immunol. 1986 Mar 1;136(5):1668-75.
4
Active suppression of host-versus-graft reaction in pregnant mice. VIII. The uterine decidua-associated suppressor cell is distinct from decidual NK cells.妊娠小鼠宿主抗移植物反应的主动抑制。VIII. 子宫蜕膜相关抑制细胞与蜕膜自然杀伤细胞不同。
Cell Immunol. 1986 Apr 15;99(1):140-9. doi: 10.1016/0008-8749(86)90223-6.
5
Local active suppression by suppressor cells in the decidua: a review.蜕膜中抑制细胞的局部主动抑制作用:综述
Am J Reprod Immunol (1980). 1984 Mar;5(2):78-83. doi: 10.1111/j.1600-0897.1984.tb00293.x.
6
A novel suppressor cell develops in uterine decidua in response to fetal trophoblast-type cells.一种新型抑制细胞在子宫蜕膜中发育,以响应胎儿滋养层样细胞。
Reg Immunol. 1988 Nov-Dec;1(3):182-9.
7
PGE2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity.孕早期人蜕膜细胞通过PGE2介导的免疫抑制作用阻断蜕膜中母体白细胞的激活,具有潜在的抗滋养层细胞活性。
Cell Immunol. 1989 Apr 15;120(1):61-74. doi: 10.1016/0008-8749(89)90174-3.
8
Active suppression of host-vs-graft reaction in pregnant mice. IV. Local suppressor cells in decidua and uterine blood.妊娠小鼠宿主抗移植物反应的主动抑制。IV. 蜕膜和子宫血液中的局部抑制细胞。
J Reprod Immunol. 1982 Dec;4(6):355-64. doi: 10.1016/0165-0378(82)90010-9.
9
Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.髓系来源的抑制细胞耗竭可能通过上调蜕膜自然杀伤细胞的细胞毒性导致妊娠丢失。
Am J Reprod Immunol. 2019 Apr;81(4):e13099. doi: 10.1111/aji.13099. Epub 2019 Mar 4.
10
Immunosuppressor factor(s) produced by decidua-associated suppressor cells: a proposed mechanism for fetal allograft survival.蜕膜相关抑制细胞产生的免疫抑制因子:胎儿同种异体移植存活的一种可能机制。
Am J Obstet Gynecol. 1987 Feb;156(2):344-50. doi: 10.1016/0002-9378(87)90281-x.

引用本文的文献

1
Melanoma in pregnancy.妊娠期黑色素瘤
Obstet Med. 2017 Sep;10(3):107-112. doi: 10.1177/1753495X17695001. Epub 2017 Mar 20.
2
Endometrial granulocytes in human decidua react with a natural-killer (NK) cell marker, NKH1.人蜕膜中的子宫内膜粒细胞与一种自然杀伤(NK)细胞标志物NKH1发生反应。
Immunology. 1987 Oct;62(2):329-31.
3
Site-directed differences in the immune response to the fetus.针对胎儿的免疫反应中的位点定向差异。
Immunology. 1989 Feb;66(2):312-7.
4
Isolation and functional studies of granulated lymphocytes in first trimester human decidua.孕早期人蜕膜中颗粒淋巴细胞的分离及功能研究
Clin Exp Immunol. 1989 Aug;77(2):263-8.
5
Expression on cells of early human pregnancy decidua, of the p75, IL-2 and p145, IL-4 receptor proteins.早期人类妊娠蜕膜细胞上p75、IL-2以及p145、IL-4受体蛋白的表达。
Immunology. 1991 May;73(1):64-70.
6
Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy.人类妊娠母胎界面细胞中肿瘤坏死因子产生的定位。
Clin Exp Immunol. 1992 Apr;88(1):174-80. doi: 10.1111/j.1365-2249.1992.tb03059.x.